Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05294302 · ClinicalTrials.gov registry record · NA

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

A NA study of Pediatric Cancer, sponsored by Nemours Children's Clinic.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
3
Study locations

NCT05294302: Recruiting NA study of Pediatric Cancer, sponsored by Nemours Children's Clinic.

NCT05294302 is a NA study of Pediatric Cancer that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 350 participants, below the 1,484-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (76% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05294302, a NA study of Pediatric Cancer, is actively recruiting participants, sponsored by Nemours Children's Clinic.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
3
Study locations

Study Summary

It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) with study endpoints focused on decreasing negative psychosocial sequelae (acute distress, posttraumatic stress, and anxiety) and improving coping abilities (coping self-efficacy, cognitive coping strategies). The long-term goal of this research program is to sustain and disseminate an effective, scalable, high-reach, and cost-effective intervention to provide crucial support to PCCC across the pediatric cancer trajectory.

Primary Outcome

Questionnaire to measure acute distress.

Conditions Studied

Interventions

  • BEHAVIORAL eSCCIP/eSCCIP-SP
  • BEHAVIORAL Coping Space

Study Locations (3)

California

  • Children's Hospital Los Angeles - Los Angeles

Delaware

  • Nemours Children's Health, Delaware - Wilmington

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2023-04-14
Est. Completion 2026-06-30
Phase NA
Nemours Children's Clinic

108 total trials

What NCT05294302 shows while recruiting

NCT05294302 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,484-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which eSCCIP/eSCCIP-SP is the first listed.

NCT05294302 reports a single indexed study location in California, Delaware, Texas.

Frequently Asked Questions

What is clinical trial NCT05294302 about?

NCT05294302 is a clinical study titled "Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer". It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) w...

What is the current status of trial NCT05294302?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2023-04-14. Estimated completion is 2026-06-30.

What conditions does trial NCT05294302 study?

This clinical trial studies the following conditions: Pediatric Cancer.

What interventions are being tested in trial NCT05294302?

The interventions under investigation include: eSCCIP/eSCCIP-SP (BEHAVIORAL), Coping Space (BEHAVIORAL).

Who is sponsoring clinical trial NCT05294302?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05294302 being conducted?

This trial has 3 study locations across California, Delaware, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05294302's enrollment target sits among peer trials

350 12th of 51 higher than 40 of 51 other Pediatric Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05294302, the US trial registry maintained by the National Library of Medicine. NCT05294302 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.